{
  "symbol": "AMGN",
  "period": "2021",
  "report_type": "YearlyIncomeStatement",
  "items": {
    "Tax Effect Of Unusual Items": 0.0,
    "Tax Rate For Calcs": 0.108,
    "Normalized EBITDA": 12169000000.0,
    "Total Unusual Items": 0.0,
    "Total Unusual Items Excluding Goodwill": 0.0,
    "Net Income From Continuing Operation Net Minority Interest": 6552000000.0,
    "Reconciled Depreciation": 3417000000.0,
    "Reconciled Cost Of Revenue": 6406000000.0,
    "EBITDA": 12169000000.0,
    "EBIT": 8752000000.0,
    "Net Interest Income": -1406000000.0,
    "Interest Expense": 1406000000.0,
    "Normalized Income": 6552000000.0,
    "Net Income From Continuing And Discontinued Operation": 6552000000.0,
    "Total Expenses": 16757000000.0,
    "Total Operating Income As Reported": 9566000000.0,
    "Diluted Average Shares": 541000000.0,
    "Basic Average Shares": 538000000.0,
    "Diluted EPS": 12.11,
    "Basic EPS": 12.18,
    "Diluted NI Availto Com Stockholders": 6552000000.0,
    "Net Income Common Stockholders": 6552000000.0,
    "Net Income": 6552000000.0,
    "Net Income Including Noncontrolling Interests": 6552000000.0,
    "Net Income Continuous Operations": 6552000000.0,
    "Tax Provision": 794000000.0,
    "Pretax Income": 7346000000.0,
    "Other Income Expense": -814000000.0,
    "Other Non Operating Income Expenses": -814000000.0,
    "Special Income Charges": 0.0,
    "Net Non Operating Interest Income Expense": -1406000000.0,
    "Interest Expense Non Operating": 1406000000.0,
    "Operating Income": 9566000000.0,
    "Operating Expense": 10351000000.0,
    "Other Operating Expenses": 503000000.0,
    "Research And Development": 4434000000.0,
    "Selling General And Administration": 5414000000.0,
    "Gross Profit": 19917000000.0,
    "Cost Of Revenue": 6406000000.0,
    "Total Revenue": 26323000000.0,
    "Operating Revenue": 24801000000.0
  }
}